The Future of British Hemp
Join the UK's first precision-bred hemp genetics company. Government-backed technology, massive market opportunity, and significant tax benefits for qualifying investors.



Investor Portal
Access exclusive investment materials and detailed market data
What's Inside
- Detailed market analysis & financial projections
- EU & global hemp farming statistics
- Government backing from 30+ countries
- SEIS/EIS tax benefit calculator
- Funding history & use of funds breakdown
- Exit scenarios & competitive analysis

Already have a PIN? Enter here
Why invest in Precision Plants?
Precision Plants is developing the UK's first precision-bred, THC-free hemp varieties using CRISPR gene editing, targeting a global industrial hemp market projected to reach $18.6 billion by 2027 (CAGR 22.4%). The company qualifies for SEIS (50% income tax relief) and EIS (30% income tax relief) under HMRC advance assurance, with additional capital gains tax exemption on qualifying shares — providing up to 78% effective tax relief for eligible investors.
Backed by £912,000 in DEFRA government funding and a research partnership with Rothamsted Research, Precision Plants is the only UK company with precision-bred hemp genetics. The Precision Breeding Act 2023 provides a clear regulatory pathway, and UK hemp hectarage is targeted to triple by 2030 under government policy. — Grand View Research 2024
Why Invest in Precision Plants?
We're developing the UK's first precision-bred hemp varieties (10-13 CRISPR edits per variety), solving the critical THC compliance problem that has held back British hemp farming for decades. With government backing, exclusive research partnerships, and a clear regulatory pathway, we're positioned to capture a significant share of a rapidly growing market.

Ready to Grow the Future of
British Agriculture?
"There is only one known annually renewable natural resource… capable of providing the majority of the world's paper and textiles… energy needs, while simultaneously reducing pollution… and that substance is… Cannabis hemp."
Join our farm trial programme or register your interest for our 2032 commercial seed release.